Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. [electronic resource]
Producer: 20140317Description: 4239-48 p. digitalISSN:- 1557-3265
- Adolescent
- Carcinoma, Medullary -- drug therapy
- Carcinoma, Neuroendocrine
- Child
- Child, Preschool
- Drug-Related Side Effects and Adverse Reactions -- pathology
- Gene Expression Regulation, Neoplastic
- Germ-Line Mutation
- Humans
- Multiple Endocrine Neoplasia Type 2b -- drug therapy
- Neoplasm Metastasis
- Neoplasm Recurrence, Local -- drug therapy
- Piperidines -- administration & dosage
- Protein-Tyrosine Kinases -- genetics
- Proto-Oncogene Mas
- Proto-Oncogene Proteins c-ret -- genetics
- Quinazolines -- administration & dosage
- Thyroid Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.